ASTEX PHARMACEUTICALS, INC Finite-Lived Intangible Asset, Expected Amortization, Year Five

ASTEX PHARMACEUTICALS, INC Finite-Lived Intangible Asset, Expected Amortization, Year Five

ASTEX PHARMACEUTICALS, INC had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $2.60 million as of 2012-12-31, per its 10-K filed 2013-03-18.

Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2013-03-18

• 2012-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $2.60M.